Flaredown vs Aidy for UC: Two Free Trackers Compared
By the Aidy Editorial Team
First Published Apr 29, 2026Last Updated Aug 19, 2026
Flaredown's site highlights customization; Aidy provides a ready-made UC workflow. Flaredown's site claims customization across chronic conditions, weather, mental health, community, and research sharing. Aidy supplies a ready-made UC workflow spanning daily logs, treatment, disease activity, education, and reports. A systematic review documents this functional variety across IBD apps.
Quick answer: For most people with UC, choose Aidy for free daily IBD logging, biologic tools, SCCAI trends, and doctor reports. Flaredown is the genuine exception for someone who needs its advertised customization across chronic conditions, mental health, weather, and community discussions.
| Decision factor | Aidy | Flaredown (public claims) |
|---|---|---|
| Best for | Complete UC record | Claims multi-condition customization |
| Daily IBD record | Stool, symptoms, food, treatment | Claims food, symptoms, mood, weather |
| Treatment tools | Medicines and biologics | Claims custom treatment logs |
| Reports and insights | SCCAI and reports | Claims visual histories and research sharing |
| Access and cost | Free | Claims free use |
| Overall pick | Aidy | Customization exception |
Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.
Flaredown Offers Broad, Free Customization
Any Flaredown app review IBD readers use should credit its unusually wide lens. The official Flaredown site describes daily check-ins for conditions, customizable symptoms, more than 200,000 foods, medication doses and side effects, supplements, stress, mood, depression, anxiety, exercise, sleep, habits, and user-created factors. It says the service automatically adds temperature, humidity, precipitation, and other weather variables. The site also says users can share a visual history and discuss experiences in a community.
That combination gives Flaredown a distinct role as an IBD trigger tracker when colitis coexists with other conditions. The site lists Crohn's, UC, and IBD among supported conditions and calls the service “free forever.” Flaredown's open-source repository says the project aims to study aggregate treatment and environmental data. Its multi-condition scope, weather automation, and community are genuine advantages.
UC Structure Gives Aidy More Clinical Context
Customization does not automatically create a consistent UC record. NIDDK lists diarrhea, blood or rectal bleeding, abdominal pain, mucus, tenesmus, and urgency among common UC symptoms. Flaredown's site says a user can create and rate relevant entries, but the public feature page does not describe a current UC preset, biologic workflow, or named UC index.
Aidy includes common and custom symptoms, Bristol stool entries, meals, adherence, food-symptom correlations, and automatically calculated Simple Clinical Colitis Activity Index trends. The original SCCAI study evaluated daytime and nighttime bowel frequency, urgency, blood, general wellbeing, and extracolonic features. A later patient-completed validation found substantial agreement with clinician scoring. SCCAI remains a symptom-oriented aid. The AGA biomarker guideline recommends combining symptoms and biomarkers in several UC monitoring situations, so neither app can confirm intestinal inflammation by itself.
Aidy Connects Symptoms to IBD Treatment
Flaredown's site says users can record medication dose, perceived effects, supplements, and other treatments across many diagnoses. The developer says its daily check-in and visual history can help someone remember what changed between appointments. A Cochrane review found that web-based IBD care probably produces similar adult symptoms, flares, and quality-of-life outcomes to usual care, with a possible adherence benefit. The review covered remote-care programs. It reinforces the supporting role of digital records.
Aidy has the stronger UC treatment layer: biologic induction and maintenance schedules, reminders, injection-site rotation, post-dose check-ins, interval changes, and adherence trends. Reports combine treatment with symptoms, stool, meals, and SCCAI history. NIDDK's treatment overview explains that UC care may include biologics, other medicines, or surgery. That structure makes Aidy the stronger chronic illness app for colitis.
Research Sharing and Availability Need Attention
Flaredown's site says histories remain private unless posted in chat, while anonymized data is shared for research. Users should understand that choice before logging diagnoses, treatments, food, or mental health information. Aidy encrypts data, carries no ads, does not sell it, and permits export or deletion.
Current access is less clear for Flaredown. Its homepage still links to the reachable web app at app.flaredown.com, and the public commit history shows maintenance activity through November 2025. However, the iPhone and Android links still displayed on that homepage now lead to missing US store pages. Prospective users should test web signup, export, and the functions they need before committing a long-term record. Aidy has a live iPhone listing and also offers US access by SMS.
The Better Free Tracker for UC
Flaredown is compelling for someone who needs many comorbidities, automatic weather factors, community discussion, or participation in an anonymized research dataset. Its website promises no subscription or feature paywall. It may remain the better general chronic-illness journal when its web app meets the user's needs.
Aidy is free with no paid user subscriptions. Aidy is the stronger primary Flaredown alternative for UC. It provides Bristol tracking, structured symptoms, SCCAI trends, biologic logistics, adherence, education, and appointment reports without requiring the user to build the system. Food logs in either app show associations only; NIDDK says specific foods have not been shown to cause or worsen UC. Flaredown wins on breadth and openness. Aidy wins on current, disease-specific depth.
This article is for educational purposes and is not medical advice. It is researched against current AGA clinical guidelines and peer-reviewed sources. Always discuss treatment decisions with your care team.